CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
February 24, 2026—iVascular announced the enrollment of the first patient in the FENCO clinical study evaluating the company’s iCover ball ...
1don MSN
Adagio Medical (ADGM) Announces Successful Results From US Cardiac Ablation Feasibility Study
Adagio Medical Holdings Inc. (NASDAQ:ADGM) is one of the best up and coming penny stocks to buy. On February 4, Adagio Medical Holdings announced the publication of results from its US Early ...
Atrial fibrillation is the most common form of heart rhythm disorder and is linked to serious complications, including stroke and heart failure. While earlier research pointed to a possible ...
A large, multi-center study published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides new ...
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
India: A recent multicenter study published in the Indian Journal of Medical Research in September 2025 reports that the ...
Shriners Children’s is leading a multi-center study that they hope will improve standards of care for burn patients everywhere and could potentially lead to insurance companies changing their coverage ...
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results